P28223 (5HT2A_HUMAN) Homo sapiens (Human)
5-hydroxytryptamine receptor 2A UniProtKBInterProSTRINGInteractive Modelling
Available Structures
18 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| 5-HT2AR bound to Lisuride in complex with a mini-Gq protein and an active-state stabilizing single-… |
Heteromer P59768; P62873; | 100.0 | 1×H8G; | |||
| 5-HT2AR bound to a novel agonist in complex with a mini-Gq protein and an active-state stabilizing … |
Heteromer P59768; P62873; | 100.0 | 1×3IQ; | |||
| 5HT2AR-miniGq heterotrimer in complex with a novel agonist obtained from large scale docking |
Heteromer P59768; P62873; | 100.0 | 1×YEQ; | |||
| HTR2A bound to 25-CN-NBOH in complex with a mini-Galpha-q protein, beta/gamma subunits and an activ… |
Heteromer P59768; P62873; | 100.0 | 1×U0G; | |||
| Crystal structure of serotonin 2A receptor in complex with psilocin | monomer | 88.89 | 1×MG; 2×CLR; 3×OLC; 1×91Q; | |||
| Crystal structure of serotonin 2A receptor in complex with serotonin | monomer | 89.12 | 3×CLR; 1×1PE; 3×OLC; 1×MG; 1×SRO; | |||
| Crystal structure of serotonin 2A receptor in complex with lumateperone | monomer | 98.95 | 1×MG; 4×CLR; 1×1PE; 11×OLC; 1×92S; 1×PEG; | |||
| Crystal structure of serotonin 2A receptor in complex with non-hallucinogenic psychedelic analog | monomer | 98.94 | 1×MG; 3×CLR; 6×OLC; 1×93F; 1×1PE; 2×PEG; | |||
| Crystal structure of serotonin 2A receptor in complex with lisuride | monomer | 98.94 | 1×MG; 1×CLR; 1×1PE; 5×OLC; 3×PEG; 1×H8G; | |||
| Crystal structure of 5-HT2AR in complex with zotepine | monomer | 98.98 | 1×ZOT; 1×CLR; 1×1PE; 1×ZN; | |||
| Crystal structure of 5-HT2AR in complex with risperidone | monomer | 98.98 | 1×8NU; 1×CLR; 1×ZN; 3×1PE; | |||
| Crystal structure of HTR2A with inverse agonist | monomer | 99.48 | 1×89F; 2×OLA; 1×CLR; 1×PEG; | |||
| Crystal structure of serotonin 2A receptor in complex with LSD | monomer | 98.92 | 1×MG; 1×CLR; 4×OLC; 1×7LD; 1×1PE; 3×PEG; | |||
| Crystal structure of 5-HT2AR in complex with (R)-IHCH-7179 | monomer | 98.92 | 1×MG; 1×EZX; 7×OLC; 2×CLR; 1×1PE; 2×PEG; | |||
| Crystal structure of 5-HT2AR in complex with aripiprazole | monomer | 98.92 | 3×CLR; 1×1PE; 4×OLC; 1×9SC; 1×MG; | |||
| Crystal structure of 5-HT2AR in complex with cariprazine | monomer | 98.92 | 1×MG; 3×CLR; 3×OLC; 1×7RU; | |||
| Crystal structure of HTR2A with hallucinogenic agonist | monomer | 99.47 | 1×7LD; 2×CLR; 2×OLA; 1×PEG; | |||
| Crystal structure of an inverse agonist antipsychotic drug pimavanserin-bound 5-HT2A | monomer | 98.96 | 1×A1L11; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7wc4.1.A | monomer | 0.73 | 3×CLR; 3×OLC; 1×SRO; | 85.71 | ||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 6a93.1.A | monomer | 0.67 | 1×ZN; | 75.34 | ||